Studies like the PRIMARY study demonstrated the potential of PSMA-PET/CT as compared to that for mpMRI and PI-RADS score for determining whether a clinically significant prostate cancer is present [2,7]. This evidence concerns the gene FOLH1 and Familial prostate cancer.